BridgeMD
New treatment option for Anterior Cruciate Ligament Tear
Official title Effect of ACL Reconstruction in Biomechanical Properties of Ankle Joint Complex
ClinicalTrials.gov ID: NCT06631690
What this study is testing
- What it's testing
- BACKGROUND: Anterior cruciate ligament (ACL) is an important ligamentous structure in the knee joint which contributes in maintaining stability. ACL injury contribute to approximately 50% of knee injuries .The incidence of ACL ruptures is estimated to be between 30 and 78 per 100,000 people per year .
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 45
You may be able to join if
- Age ranging between 15- 45 years
- Having unilateral isolated ACL tear with no concomitant tear of other ligaments of the knee
- Having no evidence of meniscal repair
- Having bilateral healthy ankle before surgery.
You likely can't join if
- Pre-existing ankle injury or ankle instability
- Associated ligament injury, chondral damage, meniscal injury, fracture around the knee, and presence of pathologic condition in the lower extremity...
- Visible mal-alignments in the lower extremities.
- Previous surgery to the affected knee.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.